Alpha DNA Investment Management’s iShares MSCI EAFE ETF EFA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,070
Closed -$220K 175
2023
Q1
$220K Buy
+3,070
New +$215K 0.06% 143
2021
Q2
Sell
-2,220
Closed -$168K 258
2021
Q1
$168K Sell
2,220
-390
-15% -$29.4K 0.19% 103
2020
Q4
$190K Buy
+2,610
New +$178K 0.2% 105

Other funds holding EFA

Alpha DNA Investment Management's EFA Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of iShares MSCI EAFE ETF (EFA) in Q2 2023, closing a stake of 3,070 shares — an estimated $220K sold.

Alpha DNA Investment Management first reported a position in EFA in Q4 2020 and held it in 3 quarters. The position peaked at $220K in Q1 2023. 1,778 funds tracked by Wall St. Rank hold EFA as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining iShares MSCI EAFE ETF position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,070 iShares MSCI EAFE ETF shares in Q2 2023, an estimated $220K.
  • Alpha DNA Investment Management first reported a position in iShares MSCI EAFE ETF in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's iShares MSCI EAFE ETF position peaked at $220K in Q1 2023.
  • 1,778 funds tracked by Wall St. Rank held iShares MSCI EAFE ETF as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.